These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7653481

  • 1. Etidronate in the management of glucocorticoid-induced osteoporosis.
    Lukert BP.
    Am J Med; 1995 Sep; 99(3):233-4. PubMed ID: 7653481
    [No Abstract] [Full Text] [Related]

  • 2. Etidronate and glucocorticoid induced osteoporosis.
    Ortego-Centeno N, Muñoz-Torres M, Callejas-Rubio JL, Riera-Montes M.
    J Rheumatol; 2005 Jan; 32(1):199-200. PubMed ID: 15630758
    [No Abstract] [Full Text] [Related]

  • 3. [Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium].
    Pneumologie; 2005 Feb; 59(2):94. PubMed ID: 15724219
    [No Abstract] [Full Text] [Related]

  • 4. Etidronate: what is its place in treatment of primary osteoporosis and other demineralizing diseases today?
    Ioachimescu A, Licata A.
    Curr Osteoporos Rep; 2007 Dec; 5(4):165-9. PubMed ID: 18430391
    [Abstract] [Full Text] [Related]

  • 5. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?
    Lems WF, Jacobs JW, Bijlsma JW, van Veen GJ, Houben HH, Haanen HC, Gerrits MI, van Rijn HJ.
    Ann Rheum Dis; 1997 Jun; 56(6):357-63. PubMed ID: 9227164
    [Abstract] [Full Text] [Related]

  • 6. Management of glucocorticoid-induced osteoporosis: What is new?
    Compston J.
    Int J Rheum Dis; 2019 Sep; 22(9):1595-1597. PubMed ID: 31478605
    [No Abstract] [Full Text] [Related]

  • 7. Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
    Compston JE.
    Gut; 1999 Jun; 44(6):780-1. PubMed ID: 10375295
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.
    Cowan S, Morin S, Ernst P.
    Thorax; 1998 May; 53(5):331-2. PubMed ID: 9708219
    [No Abstract] [Full Text] [Related]

  • 9. Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
    Loddenkemper K, Grauer A, Burmester GR, Buttgereit F.
    Clin Exp Rheumatol; 2003 May; 21(1):19-26. PubMed ID: 12673885
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
    Cortet B, Hachulla E, Barton I, Bonvoisin B, Roux C.
    Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid-induced osteoporosis: hope on the HORIZON.
    Gennari L, Bilezikian JP.
    Lancet; 2009 Apr 11; 373(9671):1225-6. PubMed ID: 19362657
    [No Abstract] [Full Text] [Related]

  • 12. [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
    Sato S.
    Clin Calcium; 2007 Apr 11; 17(4):600-5. PubMed ID: 17404491
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. How to prevent glucocorticoid-induced osteoporosis.
    Bachmeyer C, Gauthier M.
    Cleve Clin J Med; 2010 Nov 11; 77(11):762; author reply 762. PubMed ID: 21086710
    [No Abstract] [Full Text] [Related]

  • 15. [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y.
    Clin Calcium; 2006 Nov 11; 16(11):1834-42. PubMed ID: 17079850
    [Abstract] [Full Text] [Related]

  • 16. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M.
    J Rheumatol; 2003 Dec 11; 30(12):2673-9. PubMed ID: 14719212
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroid-induced bone loss.
    Millard PS.
    J Fam Pract; 1996 Apr 11; 42(4):347. PubMed ID: 8627196
    [No Abstract] [Full Text] [Related]

  • 18. Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.
    Canalis E.
    J Clin Endocrinol Metab; 1996 Oct 11; 81(10):3441-7. PubMed ID: 8855781
    [No Abstract] [Full Text] [Related]

  • 19. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.
    Thorax; 1998 May 11; 53(5):351-6. PubMed ID: 9708225
    [Abstract] [Full Text] [Related]

  • 20. Preliminary study of etidronate for prevention of corticosteroid-induced osteoporosis caused by oral glucocorticoid therapy.
    Furukawa F, Kaminaka C, Ikeda T, Kanazawa N, Yamamoto Y, Ohta C, Nishide T, Tsujioka K, Hattori M, Uede K, Hata M, Wakayama Study Group on Dermatological Use of Bisphosphonates.
    Clin Exp Dermatol; 2011 Mar 11; 36(2):165-8. PubMed ID: 20497186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.